Scientists and algorithms: Finding the right balance in mode...
The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Newsletters and Deep Dive digital magazine
The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.
We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.
With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
How can pharma lead the way in ethical AI and trust-driven innovation?
Editor's Picks
Newsletters and Deep Dive
digital magazine